Jonathan E. Shoag, MD

Highlights

1
The New England journal of medicine · 2020
JEJonathan E. Shoag JCJim C. Hu
PMID: 32558473PMCID: PMC7491201DOIFirst author79 citations
2
JAMA internal medicine · 2023
BABashir Al Hussein JEJonathan E. Shoag
PMID: 37010836PMCID: PMC10071395DOISenior author26 citations
3
Cancer · 2020
JEJonathan E. Shoag CGChristopher Gaffney JMJialin Mao MNMolly Nowels+2 more →JCJim C. Hu
PMID: 32320063DOIFirst author22 citations

209

Completed grants (3)

PI
Direct measurement of the male germline mutation rate using sequential sperm samples
NICHD · 2021–2024 · via NIH RePORTER
R21HD105910-02
PI
Harnessing clinical data to identify new prostate cancer therapeutics
Damon Runyon Cancer Research Foundation · 2019–2020
DRCRF 23-19
MPI
Repurposing drugs for prostatic disease, a high-throughput imaging based approach
American Urological Association · 2018–2019
UCF 180747-01

Benefits of PSA Prostate Cancer Screening Found to Be More Favorable than Previous Estimates, Especially for Blacks
May 15, 2022
New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific antigen (PSA) blood test has remarkably favorable tradeoffs.
Commentary: Benefits of PSA Test for Prostate Cancer Substantially Greater than Generally Appreciated
June 17, 2020
The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian, University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center.